Medtronic plc (MDT)
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Glenmede Investment Management LP Decreases Stake in Medtronic PLC $MDT
Glenmede Investment Management LP cut its stake in shares of Medtronic PLC (NYSE: MDT) by 5.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 507,406 shares of the medical technology company's stock after selling 31,401 shares during the quarter.
Game Creek Capital LP Has $5.83 Million Stock Position in Medtronic PLC $MDT
Game Creek Capital LP increased its position in shares of Medtronic PLC (NYSE: MDT) by 231.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 61,250 shares of the medical technology company's stock after buying an additional 42,750 shares during
Medtronic plc (MDT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Medtronic plc (MDT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Medtronic plc (MDT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
MiniMed Group: Medtronic's Diabetes Business Does Not Convince
MiniMed Group trades at a modest 2x sales but struggles with persistent operating losses despite 10-15% annual revenue growth. The IPO priced below range at $20/share, raising $560M; Medtronic retains 90% ownership, and MiniMed holds $350M net cash. MiniMed faces intense competition and execution risks as a standalone entity, with profitability elusive despite a large addressable diabetes market.
Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut
Shares of MiniMed , the diabetes business of medical device maker Medtronic , opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion.
Medtronic's diabetes unit MiniMed raises $560 million in US IPO
MiniMed, the diabetes business of medical device maker Medtronic , said on Thursday it has raised $560 million in its U.S. initial public offering.
Medtronic Debuts MiniMed Go Smart MDI With Simplera Sensor in Europe
MDT launches MiniMed Go Smart MDI with the Simplera sensor in Europe, advancing connected insulin care as the Diabetes unit's IPO plans progress.
1 Reason I'd Buy Medtronic Stock and Never Sell
Medtronic is one of the world's largest medical device companies. Its dividend streak speaks volumes about the strength of its business.
Medtronic's “Textbook” Reversal: How High Can It Really Go in 2026?
Medtronic's NYSE: MDT stock price is amid a textbook reversal, having formed a Head & Shoulders Pattern and broken to fresh highs, confirming the baseline as a critical pivot point. The question now is how high the stock might rise.
Medtronic plc (MDT) Q3 2026 Earnings Call Transcript
Medtronic plc (MDT) Q3 2026 Earnings Call Transcript
